Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Amgen
Woman and Man Max 99 years
Amgen, Inc
Update Il y a 4 ans
A Study of the Effects of AMG 334 to Prevent Migraine Headaches
To evaluate the effect of AMG 334 compared to placebo on the change from baseline in monthly migraine days, in subjects with episodic migraine
Country
None
organs
None
Specialty
None
unknown
More information
Man
Between 30 years
and 99 years
Amgen
Update Il y a 4 ans
Essai de phase 3 randomisé en double aveugle comparant la survenue ou l'aggravation d'opacifications du cristallin, chez des patients ayant un cancer non métastatique de la prostate recevant le dénosumab pour le traitement d’une perte osseuse due à un traitement de privation androgénique. [essai clos aux inclusions]
L’objectif de cet essai est d’évaluer l’effet du dénosumab sur la survenue ou l'aggravation d'opacifications du cristallin, chez des patients ayant un cancer non métastatique de la prostate. Les pati...
Country
France
organs
Prostate
Specialty
Thérapies Ciblées
Essai clos aux inclusions
More information
Woman
Between 18 years
and 99 years
Amgen
Update Il y a 4 ans
Amgen 20062042 : Essai de phase 1 évaluant la tolérance de l'AMG 386 en association avec soit du paclitaxel et du trastuzumab, soit de la capécitabine et du lapatinib, chez des patientes ayant un cancer du sein HER2+. [Informations issues du site clinicaltrials.gov et traduites par l'INCa] [essai clos aux inclusions]
An open-label study of AMG 386 in combination with either paclitaxel and trastuzumab or capecitabine and lapatinib in subjects with HER2-positive locally recurrent or metastatic breast cancer
Country
France
organs
Sein
Specialty
Thérapies Ciblées
,
Chimiothérapie
Essai clos aux inclusions
More information
Woman and Man Max 99 years
Amgen, Inc
Update Il y a 4 ans
A Randomized, Placebo Controlled Study Evaluating the Efficacy and Safety of AMG 531 Treatment of Thrombocytopenic Subjects with Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Prior to Splenectomy
To evaluate the efficacy of AMG 531 in the treatment of thrombocytopenia in subjects with ITP as measured by the platelet response
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man
Between 18 years
and 99 years
Amgen
Update Il y a 4 ans
AMGEN 20060534 : Essai de phase 1b-2 évaluant la tolérance puis l’efficacité d'une chimiothérapie à base de platine associée à de l’AMG479 ou à de l’AMG102, en traitement de première ligne, chez des patients ayant un cancer du poumon à petites cellules. [Informations issues du site clinicaltrials.gov et traduites par l'INCa] [essai clos aux inclusions]
Amgen protocol 20060534 - A phase 1b/2 trial of AMG 479 or AMG 102 in combination with platinum-based chemotherapy as first-line treatment for extensive stage small cell lung cancer.
Country
France
organs
Poumon, type à petites cellules
Specialty
Chimiothérapie
Essai clos aux inclusions
More information
Woman Max 99 years
Amgen, Inc
Update Il y a 4 ans
A Study to Evaluate the Effect of Treatment with AMG 785 in Postmenopausal Women with Osteoporosis Previously Treated with BisphosphonateTherapy
Evaluate the effect of treatment with AMG 785 for 12 months, compared with teriparatide (TPTD), on total hip bone mineral density (BMD), as assessed by dual energy X-ray absorptiometry (DXA), in post...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Amgen, Inc
Update Il y a 4 ans
A Study of the Effects of AMG 334 to Prevent Migraine Headaches
To characterize the safety and tolerability of long-term administration of AMG 334
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Amgen, Inc
Update Il y a 4 ans
This study is being done to learn more about long-term use of evolocumab, safety and tolerability, and whether its chronic administration is associated to any side effects
- To describe the safety and tolerability of long-term administration of evolocumab.
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man
Between 2 years and 21 years
Amgen
Update Il y a 4 ans
Étude 20110261 : étude de phase 1 visant à évaluer la sécurité d’emploi et l’efficacité du talimogène laherparepvec chez des patients ayant des tumeurs avancées autres que du système nerveux central pour lesquels est indiquée une injection directe.
En dehors des tumeurs du système nerveux central, des leucémies, des lymphomes et des tumeurs osseuses et des tissus mous, les enfants peuvent être atteints d’autres types de tumeurs solides. Les tume...
Country
France
organs
Tumeurs solides
Specialty
Immunothérapie - Vaccinothérapie
,
Pédiatrie
Essai ouvert aux inclusions
More information
Woman and Man Max 99 years
Amgen, Inc
Update Il y a 4 ans
The trial is designed to determine the efficacy and safety of ABP 215 compared with Bevacizumab in subjects with advanced non-small cell lung cancer El ensayo se ha diseñado para determinar la eficacia y la seguridad de ABP 215 comparado con bevacizumab en sujetos con cáncer de pulmón no microcítico avanzado
To compare the efficacy of ABP 215 with bevacizumab. Comparar la eficacia del ABP 2015 con la del bevacizumab.
Country
None
organs
None
Specialty
None
Closed trial
More information
Previous
4
5
6
7
8
9
10
11
12
13
Next